Literature DB >> 18698085

Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis.

Amy V Jones1, Nicholas C P Cross, Helen E White, Anthony R Green, Linda M Scott.   

Abstract

Diverse JAK2 exon 12 mutations have been described in patients with V617F-negative polycythemia vera. Development of a sensitive detection assay capable of identifying any of these mutations is required for medium-throughput diagnostic screens. Non-mutated and mutant JAK2 exon 12 alleles were amplified from patient samples and cloned into plasmid vectors, then used to determine the sensitivity of a novel high-resolution melting-curve assay designed to detect all mutant JAK2 exon 12 alleles tested. High resolution melting analysis was more sensitive than direct sequencing and capable of detecting exon 12 mutations in granulocytes at moderate levels. In a blinded analysis of DNAs from V617F-negative erythrocytosis patients, with direct sequencing and allele-specific PCR used in one laboratory and high resolution melting analysis in another, high resolution melting successfully identified JAK2 exon 12 mutations in all 4 mutation-positive patients. High resolution melting analysis is a rapid, sensitive and high-throughput technique that is suitable for screening for JAK2 exon 12 mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18698085     DOI: 10.3324/haematol.12883

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  11 in total

1.  High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms.

Authors:  Inmaculada Rapado; Silvia Grande; Enriqueta Albizua; Rosa Ayala; José-Angel Hernández; Miguel Gallardo; Florinda Gilsanz; Joaquin Martinez-Lopez
Journal:  J Mol Diagn       Date:  2009-03       Impact factor: 5.568

Review 2.  Jak2 inhibitors: rationale and role as therapeutic agents in hematologic malignancies.

Authors:  Jacqueline Sayyah; Peter P Sayeski
Journal:  Curr Oncol Rep       Date:  2009-03       Impact factor: 5.075

3.  Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis.

Authors:  Oscar Fuster; Eva Barragán; Pascual Bolufer; José Cervera; Maria José Larráyoz; Antonio Jiménez-Velasco; Joaquín Martínez-López; Ana Valencia; Federico Moscardó; Miguel Angel Sanz
Journal:  J Mol Diagn       Date:  2009-07-30       Impact factor: 5.568

4.  Nested high-resolution melting curve analysis a highly sensitive, reliable, and simple method for detection of JAK2 exon 12 mutations--clinical relevance in the monitoring of polycythemia.

Authors:  Serge Carillo; Laurent Henry; Eric Lippert; François Girodon; Isabelle Guiraud; Céline Richard; Frédérique Dubois Galopin; Cedric Cleyrat; Eric Jourdan; Robert Kralovics; Sylvie Hermouet; Thierry Lavabre-Bertrand
Journal:  J Mol Diagn       Date:  2011-05       Impact factor: 5.568

5.  Detection of exon 12 Mutations in the JAK2 gene: enhanced analytical sensitivity using clamped PCR and nucleotide sequencing.

Authors:  Todd S Laughlin; Alison R Moliterno; Brady L Stein; Paul G Rothberg
Journal:  J Mol Diagn       Date:  2010-03-04       Impact factor: 5.568

6.  Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients.

Authors:  Valerie Ugo; Sylvie Tondeur; Marie-Laurence Menot; Nadine Bonnin; Gerald Le Gac; Carole Tonetti; Veronique Mansat-De Mas; Lydie Lecucq; Jean-Jacques Kiladjian; Christine Chomienne; Christine Dosquet; Nathalie Parquet; Luc Darnige; Marc Porneuf; Martine Escoffre-Barbe; Stephane Giraudier; Eric Delabesse; Bruno Cassinat
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

7.  JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia.

Authors:  Dong Wook Jekarl; Sang Bong Han; Myungshin Kim; Jihyang Lim; Eun-Jee Oh; Yonggoo Kim; Hee-Je Kim; Woo-Sung Min; Kyungja Han
Journal:  Korean J Hematol       Date:  2010-03-31

8.  CEBPA gene mutational status: a complete screening using high-resolution melt curve analysis.

Authors:  Filip Rázga; Dana Dvoráková; Tomás Jurcek; Ivana Jezísková; Zlatuse Krístková; Jirí Mayer
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

9.  A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden.

Authors:  Lasse Kjær; Maj Westman; Caroline Hasselbalch Riley; Estrid Høgdall; Ole Weis Bjerrum; Hans Hasselbalch
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

10.  The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms.

Authors:  Zhiyuan Wu; Xinju Zhang; Xiao Xu; Yuming Chen; Tingting Hu; Zhihua Kang; Shibao Li; Hua Wang; Weiwei Liu; Xiaochao Ma; Ming Guan
Journal:  J Hematol Oncol       Date:  2014-07-15       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.